Exclusive

Publication

Byline

Location

Why Sun Pharma's hefty bid for Organon has divided investors

New Delhi, Jan. 21 -- India's largest drugmaker Sun Pharma is reportedly bidding for American pharmaceutical company Organon in a deal that could potentially be worth $10 billion, which would make it ... Read More


Bangladesh gets a head start over India in export of weight-loss drugs to emerging markets

New Delhi, Dec. 19 -- Earlier this month, the Delhi high court, in separate judgements, allowed Dr Reddy's Laboratories and Sun Pharmaceutical Industries to manufacture and export generic semaglutide ... Read More